Literature DB >> 33910831

3'UTR-CDKN2A and CDK4 Germline Variants Are Associated With Susceptibility to Cutaneous Melanoma.

David Tovar-Parra1, Sebastián Ramiro Gil-Quiñones1, John Nova1, Luz D Gutiérrez-Castañeda2.   

Abstract

BACKGROUND/AIM: Genetic variations of the CDKN2A and CDK4 gene have been associated to melanoma development. In the present study we investigated the potential associations of CDKN2A and CDK4 gene variants in a colombian population diagnosed with melanoma.
MATERIALS AND METHODS: DNA was extracted from whole blood samples from 85 patients diagnosed with cutaneous melanoma and 166 healthy controls. CDKN2A and CDK4 genes were genotyped using a high-resolution melting assay.
RESULTS: A similar distribution of CDKN2A variants 500C>G and 540C>T was found among cases (12% and 31% respectively) and controls (15% and 31% respectively). The CDKN2A variants were present in 36% of acral lentiginous melanoma and 39.47% of lentigo maligna. The haplotype analysis showed an association with susceptibility in the development of melanoma.
CONCLUSION: The presence of haplotype 500G/540C in males is associated with an increased risk of melanoma in a colombian population, especially in subjects with a family history of cancer. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Haplotype; cancer; germline variant; melanoma; susceptibility; variant

Mesh:

Substances:

Year:  2021        PMID: 33910831      PMCID: PMC8193344          DOI: 10.21873/invivo.12406

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  30 in total

1.  Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation.

Authors:  Rūta Veinalde; Aija Ozola; Kristīne Azarjana; Anders Molven; Lars A Akslen; Simona Doniņa; Guna Proboka; Ingrīda Cēma; Ainārs Baginskis; Dace Pjanova
Journal:  Melanoma Res       Date:  2013-06       Impact factor: 3.599

2.  Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.

Authors:  B Buecher; M Gauthier-Villars; L Desjardins; L Lumbroso-Le Rouic; C Levy; A De Pauw; J Bombled; C Tirapo; C Houdayer; B Bressac-de Paillerets; D Stoppa-Lyonnet
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

3.  CDKN2A common variants and their association with melanoma risk: a population-based study.

Authors:  Tadeusz Debniak; Rodney J Scott; Tomasz Huzarski; Tomasz Byrski; Andrzej Rozmiarek; Bogusław Debniak; Elzbieta Załuga; Romuald Maleszka; Józef Kładny; Bohdan Górski; Cezary Cybulski; Jacek Gronwald; Grzegorz Kurzawski; Jan Lubinski
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

4.  Analysis of G(1)/S checkpoint regulators in metastatic melanoma.

Authors:  I Sauroja; J Smeds; T Vlaykova; R Kumar; L Talve; M Hahka-Kemppinen; K Punnonen; C T Jansèn; K Hemminki; S Pyrhönen
Journal:  Genes Chromosomes Cancer       Date:  2000-08       Impact factor: 5.006

5.  Association of SNPs in CDKN2A (P14ARF) Tumour Suppressor Gene With Endometrial Cancer in Postmenopausal Women.

Authors:  Wioletta Wujcicka; Agnieszka Zajac; Krzysztof Szyllo; Beata Smolarz; Hanna Romanowicz; Grzegorz Stachowiak
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

Review 6.  The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma.

Authors:  Karen E Sheppard; Grant A McArthur
Journal:  Clin Cancer Res       Date:  2013-10-01       Impact factor: 12.531

7.  Cutaneous melanoma in Argentina: an analysis of its characteristics and regional differences.

Authors:  Dora Loria; María Graciela Abriata; Federico Santoro; Clara Latorre
Journal:  Ecancermedicalscience       Date:  2020-03-05

8.  Variants at the 9p21 locus and melanoma risk.

Authors:  Livia Maccioni; Panduranga Sivaramakrishna Rachakonda; Justo Lorenzo Bermejo; Dolores Planelles; Celia Requena; Kari Hemminki; Eduardo Nagore; Rajiv Kumar
Journal:  BMC Cancer       Date:  2013-07-02       Impact factor: 4.430

9.  Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients.

Authors:  Anna Przybyła; Katarzyna Lamperska; Andrzej Mackiewicz
Journal:  Contemp Oncol (Pozn)       Date:  2015-09-28

10.  Mutational Profile of Driver Genes in Brazilian Melanomas.

Authors:  Anna Luiza S A Vicente; Camila S Crovador; Graziela Macedo; Cristovam Scapulatempo-Neto; Rui M Reis; Vinicius L Vazquez
Journal:  J Glob Oncol       Date:  2019-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.